Toward an HIV type 1 vaccine that generates potent, broadly cross-reactive neutralizing antibodies

AIDS Res Hum Retroviruses. 1999 May 20;15(8):689-98. doi: 10.1089/088922299310773.
No abstract available

Publication types

  • Congress
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines / immunology*
  • Animals
  • Cross Reactions
  • Gene Products, env / chemistry
  • Gene Products, env / immunology
  • HIV Antibodies / biosynthesis*
  • HIV Antibodies / immunology
  • HIV Envelope Protein gp120 / chemistry
  • HIV Envelope Protein gp120 / immunology
  • HIV-1 / chemistry
  • HIV-1 / immunology*
  • Humans
  • Immunization, Passive
  • Neutralization Tests
  • env Gene Products, Human Immunodeficiency Virus

Substances

  • AIDS Vaccines
  • Gene Products, env
  • HIV Antibodies
  • HIV Envelope Protein gp120
  • env Gene Products, Human Immunodeficiency Virus
  • gp140 envelope protein, Human immunodeficiency virus 1